GB2285977B - Novel azetidine antipsychotic drugs - Google Patents

Novel azetidine antipsychotic drugs

Info

Publication number
GB2285977B
GB2285977B GB9401282A GB9401282A GB2285977B GB 2285977 B GB2285977 B GB 2285977B GB 9401282 A GB9401282 A GB 9401282A GB 9401282 A GB9401282 A GB 9401282A GB 2285977 B GB2285977 B GB 2285977B
Authority
GB
United Kingdom
Prior art keywords
antipsychotic drugs
novel azetidine
azetidine
novel
antipsychotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9401282A
Other versions
GB2285977A (en
GB9401282D0 (en
Inventor
Paul Joseph Gilligan
Paul John Krenitsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Priority to GB9401282A priority Critical patent/GB2285977B/en
Publication of GB9401282D0 publication Critical patent/GB9401282D0/en
Publication of GB2285977A publication Critical patent/GB2285977A/en
Application granted granted Critical
Publication of GB2285977B publication Critical patent/GB2285977B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9401282A 1994-01-24 1994-01-24 Novel azetidine antipsychotic drugs Expired - Fee Related GB2285977B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9401282A GB2285977B (en) 1994-01-24 1994-01-24 Novel azetidine antipsychotic drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9401282A GB2285977B (en) 1994-01-24 1994-01-24 Novel azetidine antipsychotic drugs

Publications (3)

Publication Number Publication Date
GB9401282D0 GB9401282D0 (en) 1994-03-23
GB2285977A GB2285977A (en) 1995-08-02
GB2285977B true GB2285977B (en) 1998-05-27

Family

ID=10749212

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9401282A Expired - Fee Related GB2285977B (en) 1994-01-24 1994-01-24 Novel azetidine antipsychotic drugs

Country Status (1)

Country Link
GB (1) GB2285977B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805818B1 (en) * 2000-03-03 2002-04-26 Aventis Pharma Sa AZETIDINE DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB0326221D0 (en) * 2003-11-10 2003-12-17 Merck Sharp & Dohme Therapeutic agents,compositions,preparations and uses
WO2024088409A1 (en) * 2022-10-28 2024-05-02 纽欧申医药(上海)有限公司 Nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof, preparation method therefor, and the use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077288A (en) * 1989-03-21 1991-12-31 Adir Et Compagnie 4-fluorobenzoic compounds with 5-HT2 - and α1 -antagonistic activities

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077288A (en) * 1989-03-21 1991-12-31 Adir Et Compagnie 4-fluorobenzoic compounds with 5-HT2 - and α1 -antagonistic activities

Also Published As

Publication number Publication date
GB2285977A (en) 1995-08-02
GB9401282D0 (en) 1994-03-23

Similar Documents

Publication Publication Date Title
GB9402807D0 (en) Pharmaceutical compounds
ZA959921B (en) Pharmaceutical compounds
ZA954226B (en) Pharmaceutical compounds
GB9726563D0 (en) Novel pharmaceutical
GB9502861D0 (en) Pharmaceutical compounds
GB2286394B (en) Pharmaceutical compounds
GB9426224D0 (en) Pharmaceutical compounds
GB9726566D0 (en) Novel pharmaceutical
EG23694A (en) Novel pharmaceutical
GB9418326D0 (en) Pharmaceutical compounds
GB9417102D0 (en) Pharmaceutical compounds
GB2285977B (en) Novel azetidine antipsychotic drugs
ZA9510903B (en) Pharmaceutical compounds
GB9426080D0 (en) Pharmaceutical compounds
GB9706376D0 (en) Novel pharmaceutical
ZA951175B (en) Pharmaceutical compounds
GB9405248D0 (en) Novel pharmaceutical
GB9608926D0 (en) Novel pharmaceutical
GB9402409D0 (en) Novel pharmaceutical use
GB9406052D0 (en) Pharmaceutical compounds
GB9426092D0 (en) Pharmaceutical compounds
GB9417514D0 (en) Pharmaceutical compounds
GB9417322D0 (en) Pharmaceutical compounds
GB9402889D0 (en) Pharmaceutical compounds
GB9426074D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19990124